Pulmonary Hypertension (PH) Biorepository for Translational Research
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Blood draws
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Researchers want to create a repository of blood samples and health information collected from people with PH."
- "Objective: To collect blood samples and health information from people suspected of or diagnosed with PH."
- "Participants may choose to provide new blood samples at follow-up visits."
- "Participants may opt out of providing new blood samples but remain in the study."
- "In the future, IRB approved protocols may use these blood samples to discover novel, biologically relevant, non-invasive PH biomarkers."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study collects blood samples and health information from adults who have or may have pulmonary hypertension (PH), or high blood pressure in the lungs. Researchers hope to use these samples and records to find better ways to diagnose and treat PH.
Background: Pulmonary hypertension (PH) is high blood pressure in the blood vessels of the lungs. It can lead to heart failure and death if not treated. Researchers want to create a repository of blood samples and health information collected from people with PH. They hope to use this information to find better ways to diagnose and treat PH. Objective: To collect blood samples and health information from people suspected of or diagnosed with PH. Eligibility: People aged 18 years and older who have or may have PH. Design: Researchers will collect information from participants medical records. Participants will have blood drawn from a vein. About 3 tablespoons will be collected during the study visit. The visit will last about 1 hour. Participants may choose to provide new blood samples at follow-up visits. Updated medical information may also be collected. Participants may continue to participate as long as the study is ongoing. Participants may opt out of providing new blood samples but remain in the study. All study samples will be stored at the National Institutes of Health. Health information will be stored in secure databases.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are 18 or older.
- You have PH or may have PH.
- You can understand the study consent form and are willing to sign and date it.
Who can't join
- You do not meet all the requirements listed above.
- The study doctor decides you should not have blood drawn.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
* INCLUSION CRITERIA: * Provision of signed and dated informed consent form * Males and females aged \>=18 years old * Suspected of or diagnosed with PH * Able to understand and willing to sign a written informed consent document EXCLUSION CRITERIA: Any individual who does not meet all inclusion criteria or is deemed by the local investigator not to be a blood draw candidate will be excluded from participating in this study.
Study sites (3)
MD
- University of Maryland Medical Center at Baltimore (UMB) · Baltimore, MD 21201Gautam Ramani · Study contact · Not Listed · gramani@medicine.umaryland.eduBradley Maron · Study contact · Not Listed · BMaron@som.umaryland.eduMore trials in Baltimore
- National Institutes of Health Clinical Center · Bethesda, MD 20892NIH Clinical Center Office of Patient Recruitment (OPR) · Study contact · 800-411-1222 ext. TTY dial 711 · ccopr@nih.govMore trials in Bethesda
VA
- INOVA Fairfax Hospital · Falls Church, VA 22042More trials in Falls Church